http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S54144400-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01c1e0bc0628f76dea731cda5a666ca1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08
filingDate 1978-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d3a10e23c077ef2dc703175bbf1ba4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a7d3979e29bc356efe90e03ff06edd7
publicationDate 1979-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S54144400-A
titleOfInvention Preparation of rifamycin derivative
abstract PURPOSE: To prepare 3-iminomethyl derivative of rifamycin SV, easily, in high yield, by the two stage reaction from rifamycin B or O via 3-iminomethyl derivative of rifamycin S. n CONSTITUTION: Rifamycin B or rifamycin O is converted to 3-iminomethyl derivative of rifamycin S of formula I (R is alkyl) by reacting with HCHO and a primary amine or with an aldiimino derivative of HCHO and a primary amine, in the presence of an oxidizing agent. The reaction product (1 mole) is further made to react with (substituted-)hydrazine (≥2 moles) to afford the objective 3-iminomethyl derivative of rifamycin SV of formula II (R' is hydrozono, substituted hydrazono). n COPYRIGHT: (C)1979,JPO&Japio
priorityDate 1978-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25245928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226742447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417480
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226761037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226520046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226761038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5459948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226520047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226542980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57461352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57507833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226516759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226742448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565517

Total number of triples: 39.